CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection - Summary - MDSpire

CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection

  • By

  • Magdalena Podkowik

  • Alice Tillman

  • Courtney Takats

  • Heloise Carion

  • Gregory Putzel

  • Julian McWilliams

  • Benjamin See

  • Guiqing Wang

  • Sigridh Munoz-Gomez

  • Caitlin Otto

  • Karl Drlica

  • Luciano Marraffini

  • Alejandro Pironti

  • Sarah Hochman

  • Christopher Kerantzas

  • Bo Shopsin

  • November 19, 2025

  • 0 min

Share

Objective:

To investigate the prevalence and impact of SCCmec variants associated with CRISPR-Cas on the accuracy of rapid diagnostic assays for MRSA, highlighting the significance of these variants in clinical settings.

Key Findings:
  • 64 SCCmec variants were identified from 45 patients, representing 2% of 2432 screened, indicating a concerning prevalence.
  • Misdiagnosis was limited to clonal complex 5, with 11 of 40 SCCmec/junctions evading detection by BCID2 or Xpert, which could lead to inappropriate treatment decisions.
  • Variants exhibited mecA instability and were found circulating in healthcare settings, raising concerns about their impact on infection control.
Interpretation:

The presence of CRISPR-Cas–associated SCCmec variants poses a significant threat to the accuracy of rapid MRSA diagnostics, necessitating enhanced genomic surveillance to protect public health.

Limitations:
  • The study was conducted in a single healthcare system, which may limit generalizability; further studies in diverse settings are needed.
  • The prevalence of CRISPR-Cas SCCmec variants may vary in different geographic locations, suggesting the need for broader surveillance efforts.
Conclusion:

These findings highlight the urgent need for ongoing genomic surveillance to monitor emerging diagnostic-escape variants in S. aureus, ensuring effective treatment strategies.

Original Source(s)

CRISPR-Cas–associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection

  • by Magdalena Podkowik, Alice Tillman, Courtney Takats, Heloise Carion, Gregory Putzel, Julian McWilliams, Benjamin See, Guiqing Wang, Sigridh Munoz-Gomez, Caitlin Otto, Karl Drlica, Luciano Marraffini, Alejandro Pironti, Sarah Hochman, Christopher Kerantzas, Bo Shopsin

  • November 19, 2025

Related Content

Pharmacokinetic Profile of Dalbavancin in Complicated Bacteremia Caused by Staphylococcus aureus: A Secondary Analysis

Connecting the Diagnostic Dots in HIES

Clinical case report highlights how classic features of STAT3 hyper-IgE syndrome can be routinely missed in pediatric practice

The Epidemiological Impact of Carbapenemase-Producing and Multidrug-Resistant Bacteria in Northern Morocco: Findings from a Year-Long Observational Study